Skip to main content
. 2021 May 5;121:108026. doi: 10.1016/j.yebeh.2021.108026

Table 2.

Variable associated with SVQOLIE-31 overall score in linear regression.

Factors Univariate linear regression
Multivariate linear regression
B (95% CI) p-value B (95% CI) p-value
Age −0.041 (−0.283, 0.201) 0.739
Gender −2.143 (−8.045, 3.758) 0.473
Educational Level 6.357 (1.013, 11.701) 0.020 3.038 (−1.127, 7.203) 0.151
Epilepsy Duration −0.02 (−0.278, 0.238) 0.880
Achieved regular outpatient consultation 5.315 (−5.386, 16.015) 0.327
Treatment change in the last year −10,105 (−16,863, −3,346) 0.004 −2.494 (−7.923, 2.935) 0.364
Patient is currently employed −0.467 (−6.391, 5.458) 0.876
Temporary suspension or permanent termination of employment −5.140 (−13.761, 3.482) 0.240
Significant reduction in household income −9.293 (−15.117, −3.469) 0.002 2.426 (−2.910, 7.762) 0.369
Fear of seizures −10.271 (−12.885, −7.658) <0.001 −8.562 (−11.379, −5.745) <0.001
Fear of drug supply disruption −3.377 (−6.608, −0.146) 0.041 −0.633 (−3.544, 2.279) 0.667
Fear of inability to reach neurologist −4.699 (−7.059, −2.339) <0.001 −2.085 (−4.474, 0.303) 0.086
Fear of reduction in household income −5.946 (−8.896, −2.996) <0.001 −4.376 (−7.030, −1.723) 0.001
Fear of COVID-19 −2.014 (−4.857, 0.829) 0.163
Contact with COVID-19 positive person 0.180 (−6.020, 6.381) 0.954
History of PCR confirmed COVID-19 2.371 (−5.586, 10.329) 0.555
History of recognizable symptoms of COVID-19 0.186 (−8.233, 8.605) 0.965

SVQOLIE-31 - Serbian version of the Quality of Life in Epilepsy-31.